These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16547004)

  • 1. The specific FKBP38 inhibitor N-(N',N'-dimethylcarboxamidomethyl)cycloheximide has potent neuroprotective and neurotrophic properties in brain ischemia.
    Edlich F; Weiwad M; Wildemann D; Jarczowski F; Kilka S; Moutty MC; Jahreis G; Lücke C; Schmidt W; Striggow F; Fischer G
    J Biol Chem; 2006 May; 281(21):14961-70. PubMed ID: 16547004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FKBP family proteins: immunophilins with versatile biological functions.
    Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
    Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 regulator FKBP38 is activated by Ca2+/calmodulin.
    Edlich F; Weiwad M; Erdmann F; Fanghänel J; Jarczowski F; Rahfeld JU; Fischer G
    EMBO J; 2005 Jul; 24(14):2688-99. PubMed ID: 15990872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsp90-mediated inhibition of FKBP38 regulates apoptosis in neuroblastoma cells.
    Erdmann F; Jarczowski F; Weiwad M; Fischer G; Edlich F
    FEBS Lett; 2007 Dec; 581(29):5709-14. PubMed ID: 18036348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in peptidyl-prolyl cis/trans isomerase activity and FK506 binding protein expression following neuroprotection by FK506 in the ischemic rat brain.
    Brecht S; Schwarze K; Waetzig V; Christner C; Heiland S; Fischer G; Sartor K; Herdegen T
    Neuroscience; 2003; 120(4):1037-48. PubMed ID: 12927209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuroprotective actions of FK506 binding protein ligands: neuronal survival is triggered by de novo RNA synthesis, but is independent of inhibition of JNK and calcineurin.
    Klettner A; Baumgrass R; Zhang Y; Fischer G; Bürger E; Herdegen T; Mielke K
    Brain Res Mol Brain Res; 2001 Dec; 97(1):21-31. PubMed ID: 11744159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New structural aspects of FKBP38 activation.
    Maestre-Martínez M; Haupt K; Edlich F; Jahreis G; Jarczowski F; Erdmann F; Fischer G; Lücke C
    Biol Chem; 2010 Oct; 391(10):1157-67. PubMed ID: 20707607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506.
    Gold BG; Densmore V; Shou W; Matzuk MM; Gordon HS
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1202-10. PubMed ID: 10336507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel calmodulin-Ca2+ target recognition activates the Bcl-2 regulator FKBP38.
    Edlich F; Maestre-Martínez M; Jarczowski F; Weiwad M; Moutty MC; Malesević M; Jahreis G; Fischer G; Lücke C
    J Biol Chem; 2007 Dec; 282(50):36496-504. PubMed ID: 17942410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons.
    Guo X; Dawson VL; Dawson TM
    Eur J Neurosci; 2001 May; 13(9):1683-93. PubMed ID: 11359520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective and antioxidant properties of FKBP-binding immunophilin ligands are independent on the FKBP12 pathway in human cells.
    Tanaka K; Fujita N; Higashi Y; Ogawa N
    Neurosci Lett; 2002 Sep; 330(2):147-50. PubMed ID: 12231433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From cell death to viral replication: the diverse functions of the membrane-associated FKBP38.
    Edlich F; Lücke C
    Curr Opin Pharmacol; 2011 Aug; 11(4):348-53. PubMed ID: 21514222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of the flexible N-terminal extension of FKBP38 in catalysis.
    Kang C; Ye H; Chia J; Choi BH; Dhe-Paganon S; Simon B; Schütz U; Sattler M; Yoon HS
    Sci Rep; 2013 Oct; 3():2985. PubMed ID: 24145868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bcl-2 regulator FKBP38-calmodulin-Ca2+ is inhibited by Hsp90.
    Edlich F; Erdmann F; Jarczowski F; Moutty MC; Weiwad M; Fischer G
    J Biol Chem; 2007 May; 282(21):15341-8. PubMed ID: 17379601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A charge-sensitive loop in the FKBP38 catalytic domain modulates Bcl-2 binding.
    Maestre-Martínez M; Haupt K; Edlich F; Neumann P; Parthier C; Stubbs MT; Fischer G; Lücke C
    J Mol Recognit; 2011; 24(1):23-34. PubMed ID: 20140889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of GPI compounds to display neurotrophic activity in vitro and in vivo.
    Bocquet A; Lorent G; Fuks B; Grimée R; Talaga P; Daliers J; Klitgaard H
    Eur J Pharmacol; 2001 Mar; 415(2-3):173-80. PubMed ID: 11274996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FK506 binding proteins as targets in anticancer therapy.
    Romano S; Di Pace A; Sorrentino A; Bisogni R; Sivero L; Romano MF
    Anticancer Agents Med Chem; 2010 Nov; 10(9):651-6. PubMed ID: 21182472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural roles of immunophilins and their ligands.
    Sabatini DM; Lai MM; Snyder SH
    Mol Neurobiol; 1997 Oct; 15(2):223-39. PubMed ID: 9396011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and cytotoxic evaluation of cycloheximide derivatives as potential inhibitors of FKBP12 with neuroregenerative properties.
    Christner C; Wyrwa R; Marsch S; Küllertz G; Thiericke R; Grabley S; Schumann D; Fischer G
    J Med Chem; 1999 Sep; 42(18):3615-22. PubMed ID: 10479292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria: FKBP38 and mitochondrial degradation.
    Shirane-Kitsuji M; Nakayama KI
    Int J Biochem Cell Biol; 2014 Jun; 51():19-22. PubMed ID: 24657651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.